“Holidays” for osteoporosis drugs: A case-based approach

• A “drug holiday” can be considered for patients at low fracture risk; • It is optimal after completion of five years of alendronate and three years of zoledronic acid or risedronate use; • The “drug holiday” strategy should not be implemented for denosumab, estrogen, SERMs or teriparatide....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Case Rep Womens Health
Main Authors: Anagnostis, Panagiotis, Paschou, Stavroula A., Kenanidis, Eustathios, Lambrinoudaki, Irene, Potoupnis, Michael, Tsiridis, Eleftherios, Goulis, Dimitrios G.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580330/
https://ncbi.nlm.nih.gov/pubmed/31431887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crwh.2019.e00127
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares